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OBJECTIVES This study investigated whether noninsulin dependent diabetes mellitus (NIDDM) adversely
affects the elastic properties of the coronary arteries in patients with coronary artery disease
(CAD) and NIDDM.
BACKGROUND Attenuated vascular smooth muscle dilation to exogenous donors of nitric oxide, such as
nitroglycerin, has been observed with forearm blood flow studies in patients with NIDDM.
METHODS Twenty patients with CAD and NIDDM (diabetics), and 20 patients with only CAD
(nondiabetics) were evaluated. Intracoronary ultrasound (ICUS) imaging with simultaneous
intracoronary pressure (P2) recordings were performed at the imaging site with 0.014 in
fiber-optic high fidelity pressure monitoring wire. The same wire was used as guide wire for
the ICUS catheter. Sites with less than 50% luminal stenosis by ICUS were studied.
Recordings were done before and after 300 mg of intracoronary nitroglycerin (IC-NTG).
Electrocardiographic tracings recorded simultaneously with ICUS images were used for
timing. Systolic and diastolic cross-sectional lumen area (CSLA) and coronary artery
distensibility (C-DIST) were measured, C-DIST 5 {(systolic CSLA-diastolic CSLA)/
[(intracoronary pulse pressure) 3 (diastolic CSLA)]} 3 1,000.
RESULTS Diabetics had smaller CSLA (diabetics 5 8.6 6 0.6 mm2, nondiabetics 5 11.5 6 0.5 mm2,
p , 0.01). Although C-DIST was similar before IC-NTG in the two groups, it became
significantly lower in diabetics after IC-NTG (diabetics C-DIST 5 3.02 6 0.14 mm Hg21,
nondiabetics C-DIST 5 4.21 6 0.15 mm Hg21, p , 0.01). Degrees of circumference
involved, total plaque burden and composition were similar in both groups.
CONCLUSIONS Noninsulin dependent diabetes mellitus reduces C-DIST after IC-NTG administration. (J
Am Coll Cardiol 1999;34:1075–81) © 1999 by the American College of Cardiology
Patients with diabetes mellitus have increased morbidity
and mortality due to cardiovascular disease (1). Coronary
artery disease (CAD) is a common complication of diabetes
mellitus, which frequently results in myocardial infarction
and ischemic heart disease (2).
Several mechanisms have been implicated in the patho-
genesis of CAD in patients with diabetes mellitus, such as
elevated blood glucose level, insulin resistance with hyper-
insulinemia and hyperlipidemia (3). In addition to these
mechanisms, decreased availability or activity of nitric oxide
in the coronary arterial bed of diabetic patients may play an
important role (4). Attenuated vasodilation to exogenous
donors of nitric oxide, such as nitroglycerin, has been
observed in patients with noninsulin dependent diabetes
mellitus (NIDDM), suggesting impaired vascular function
in this group of patients (5).
Experimental and clinical studies have demonstrated that
the increase in angiographic cross-sectional lumen area
(CSLA) of normal coronary arteries after nitroglycerin
administration can reach 30% to 50% from that at baseline
(6). However, angiographic studies on coronary vasoreac-
tivity to nitroglycerin in vivo have provided some conflicted
data, probably as a result of the limitations of angiography
to study vessel wall morphology and coronary artery dimen-
sions (7). Recent advances in intracoronary ultrasound
(ICUS) imaging technology have enabled real-time evalua-
tion of coronary lumen size and wall morphology in vivo
(8,9). Intracoronary imaging enables identification of the
atherosclerotic disease regardless of the presence or absence
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of an angiographically apparent lesion and permits contin-
uous measurement of changes in vascular dimensions after
nitroglycerin administration (10).
Furthermore, there are several studies that used ICUS to
assess pulsatile changes and thus elastic properties of the
coronary arterial wall in normal and diseased coronary
segments. However, in all these studies coronary lumen
changes were not related to simultaneous intracoronary
pressure recordings at the imaging site, and whenever
intracoronary pressures were measured, they were restricted
in the very proximal coronary segment (11–13).
Therefore, in this study, we attempted to evaluate coro-
nary artery distensibility (C-DIST) in diabetic and nondi-
abetic patients, before and after intracoronary nitroglycerin
(IC-NTG) injection, using a method that related pulsatile
coronary lumen changes to the simultaneously obtained
intracoronary pressure at the imaging site. Thus, we deter-
mined accurately C-DIST at different coronary segments in
both groups of patients.
METHODS
Patient population. The study patients were obtained
from 60 consecutive patients with NIDDM who underwent
diagnostic heart catheterization or percutaneous translumi-
nal coronary angioplasty (PTCA) and 50 consecutive pa-
tients without NIDDM who underwent similar procedures.
Among them were 23 patients with NIDDM and 22
patients without NIDDM who met the study criteria of
one- or two-vessel CAD. One- or two-vessel CAD was
defined as luminal stenosis in one or two vessels equal to or
more than 50% angiographically. In all patients, the coro-
nary artery that had no significant disease by angiography
was evaluated by ICUS. In case of one-vessel disease, the
coronary artery with the least luminal stenosis was selected.
Two patients with extreme tortuosity of the coronary
segment that we attempted to study (one diabetic and one
nondiabetic) and three others who had poor guiding cath-
eter support (two diabetics and one nondiabetic) were
excluded for further evaluation. Thus, 20 patients (diabetics)
with NIDDM and CAD and 20 patients with CAD
(nondiabetics) were studied. Angina pectoris was present in
all nondiabetics (duration of symptoms 8 6 1 months) and
in 12 diabetics (duration of symptoms 7 6 2 months). None
had a history of typical variant angina. All patients had
abnormal exercise stress test.
In the diabetics, 10 sites in the proximal and 3 in the
middle-left anterior descending coronary artery and 2 sites
in the proximal and 5 in the middle-right coronary artery
were evaluated. In the nondiabetics, 8 sites in the proximal
and 3 in the middle-left anterior descending coronary artery
and 2 sites in the proximal and 7 in the middle-right
coronary artery were studied.
All diabetics were followed at the diabetes outpatient
clinic and had documented fasting hyperglycemia (blood
glucose more than 7.7 mmol liter21) on more than one
occasion. There was no history of ketoacidosis in any of the
diabetic patients. Diabetic control was achieved by diet
alone or diet and oral hypoglycemic agent treatment. Aver-
age duration of diabetes was 4.2 6 2 years. Data were
confirmed by interviewing the patient and reviewing the
medical records.
Written informed consent was obtained from all patients
and the study protocol was approved by the Human Re-
search Committee of our hospital. All the above procedures
were in accordance with the institutional guidelines.
Methods. Using standard PTCA techniques after insertion
of an 8 F guiding catheter, intravenous heparin (10,000 U)
was given before guide wire manipulations. An 0.014-in.
fiber-optic high-fidelity pressure monitoring wire (Pressure-
guide wire) was used as a guide wire to obtain intracoronary
pressure from its pressure sensor, which was located at the
transition of the radiopaque floppy tip. This fiber-optic
pressure wire (14) is connected with a pressure analyzer to
show continuously mean or systolic and diastolic intracoro-
nary pressure (P2). The pressure analyzer was connected to
a DC-coupled pressure monitor system (Electronics for
Medicine DR-12, Honeywell, Phoenix) through a high-
level analogue output for screen display and recording of the
P2 wave forms.
On the screen of the Electronics for Medicine DR-12
system, in addition to the pressure guide wire tracings,
electrocardiographic tracings (ECG) as well as aortic pres-
sure (P1) wave forms were simultaneously displayed. A
fluid-filled catheter interfaced with a Statham P23D trans-
ducer was used to obtain P1 wave forms from the guiding
catheter. After calibration of the fiber-optic pressure guide
wire, the pressure-guide wire was advanced through the
ultrasound catheter until the flexible distal part with the
pressure sensor appeared just beyond the tip of the ultra-
sound probe. The ultrasound catheter was used as a protec-
tive sheath to advance the wire into the guide catheter and
up to the ascending aorta. The fiber-optic pressure moni-
toring guide wire was then advanced beyond the ultrasound
catheter, up to the tip of the guiding catheter. At that point,
Abbreviations and Acronyms
CAD 5 coronary artery disease
C-DIST 5 coronary artery distensibility
CSLA 5 cross-sectional lumen area
D-BP 5 diastolic intracoronary pressure
ECG 5 electrocardiographic tracings
IC-NTG 5 intracoronary nitroglycerin
ICUS 5 intracoronary ultrasound
NIDDM 5 noninsulin dependent diabetes mellitus
P1 5 aortic pressure
P2 5 intracoronary pressure
PTCA 5 percutaneous transluminal coronary
angioplasty
S-BP 5 systolic intracoronary pressure
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equality of pressures that were registered by the guiding
catheter and the fiber-optic wire was verified.
The wire was then positioned under fluoroscopic guid-
ance into the distal part of the coronary artery and the
ultrasound catheter was advanced over the wire. Guide wire
P2 was recorded before and after the advancement of the
ultrasound catheter to detect any changes. The ultrasound
catheter that displayed continuous intracoronary images was
immobilized in the most proximal coronary artery site that
appeared without significant disease by angiography. The
pressure guide wire was subsequently withdrawn under
fluoroscopic guidance to the point where the pressure sensor
that is located at the transition of the radiopaque floppy tip
was just beyond the ultrasound catheter tip into the coro-
nary arterial lumen (Fig. 1). At that point using an on-off
signal, simultaneous ECG and P2 of ten cardiac cycles were
recorded. The on-off signal was used to correlate electro-
cardiographic cycles displayed on the ultrasound console
monitor with the P2 tracings and ECGs recorded on the
strip chart by the Electronics for Medicine DR-12 system
(Fig. 2). Subsequently, 300 mg IC-NTG were given, and
1 min after IC-NTG administration using the on-off signal
another ten cycles were recorded.
Attempts were made to position the ultrasound catheter
in the center of the lumen. Sites of side branches, vessel
bifurcations or angular segments where the imaging plane of
the ultrasound catheter was oblique were not selected.
Coronary arteries less than 2.5 mm in diameter at their
proximal segments, by angiography, were not evaluated
because manipulations of the ultrasound catheter would
have been limited.
Angiographic findings were evaluated and determined by
consensus of two observers using at least six orthogonal
views.
None of the patients received medications for at least 8 h
before the study, and all procedures were performed in the
afternoon to avoid any possible circardian morning effect on
the coronary arteries.
The ICUS catheters (Endosonics, Rancho Cordova, Cal-
ifornia) that were used during this study were of a synthetic
aperture array electronic transducer design with a 20-MHz
operating frequency and were 1.16 mm in diameter (15).
The images were stored on a 1.27 mm super VHS videotape
for later review. Electrocardiographic tracings were contin-
uously displayed on the console screen during the study.
Plaque was defined by ICUS as an eccentric or concentric
echo-reflectant zone delimited internally by the lumen and
externally by the echo-lucent area containing the media. A
segment showing concentric or eccentric atherosclerotic
plaque was considered diseased. The plaque composition
was assessed visually. Soft plaque tissue was less dense than
the reference adventitia. Dense fibrous tissue produced
echoes that were as bright as, or brighter than, the reference
adventitia but without acoustic shadowing. Calcified tissue
produced bright echoes with acoustic shadowing.
At the end of the study left ventricular end diastolic
pressures were recorded in all patients through a fluid-filled
pigtail catheter because left ventricular end diastolic pres-
sures can alter coronary flow and conceivably affect C-DIST.
Measurements. The CSLA was defined as the area cir-
cumscribed by the ultrasound leading-edge interface be-
tween lumen and plaque or lumen and intima. Cross-
sectional area of the vessel was defined as the area inside the
echo-dense perimeter of the adventitia, including the lumen
area and the plaque area. Cross-sectional atherosclerotic
plaque burden was defined as the sum of plaque plus media
cross sectional area which was calculated by the difference of
vessel cross sectional area-lumen cross-sectional area. A
Figure 1. In vitro and in vivo presentation of the way the pressure
wire was used as a guide wire for the ultrasound catheter. On both
pictures, top arrow indicates the position of the transducer on the
ultrasound catheter and bottom arrow indicates the pressure
sensor on the pressure wire.
Figure 2. Top: Measurements of CSLA at end diastole and end
systole during the same cardiac cycle are displayed. Electrocardio-
gram is shown at the bottom of the screen after the on-off signal.
Bottom: Electrocardiogram and P1 (through the guiding catheter)
with simultaneous P2 (obtained by the pressure wire) are displayed
on the strip chart of the Electronics for medicine DR-12 system,
after the on-off signal. CSLA 5 cross-sectional lumen area;
ECG 5 electrocardiogram; P1 5 aortic pressure; P2 5 intracoro-
nary pressure.
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coronary segment with a regular lumen and without intimal
thickening was considered normal. As reported previously
(8), the criteria for abnormality defined atherosclerosis as a
maximal thickness of intimal leading edge .0.3 mm or a
sonolucent zone thickness .0.2 mm, or both. Although a
single-end diastolic frame was used for measurement, review
of the dynamic imaging sequence was routinely used to
confirm the location of the intimal leading edge.
The formula used for C-DIST was: C-DIST 5 (systolic
CSLA 2 diastolic CSLA)/[(intracoronary pulse pres-
sure) 3 (diastolic CSLA)] 3 1,000. Intracoronary pulse
pressure was obtained from the strip-chart recording. For
the determination of the largest CSLA (systolic luminal
area) and the smallest CSLA (diastolic luminal area), the
ECG guidance was used (16). All reported measurements
represent the average of three consecutive beats. Because
(systolic CSLA 2 diastolic CSLA)/(intracoronary pulse
pressure) could be influenced by a change in blood pressure,
the stiffness index (beta) (13), which is considered to be
independent of the changes in blood pressure, was obtained,
essentially by normalizing dimension change to the diastolic
mean diameter according to the following formula: beta 5
{ln [systolic intracoronary pressure (S-BP)/D-BP]}/
{(difference between systolic and diastolic mean diameters)/
(diastolic mean diameter)}. The systolic and diastolic mean
diameters were calculated from those areas with the as-
sumption that the cross section was circular [diameter 5
2(area/p)1/2], where p 5 3.14.
Interobserver and intraobserver variabilities. The CSLA
of 10 randomly selected sites were measured by two inde-
pendent observers and by one observer two separate times.
These data were used to obtain the inter- and intra-observer
variability. The results were expressed as a linear regression
between the two measurements and as a percent error that
was derived as the absolute difference between measure-
ments derived by the initial measurements (17).
Statistical analysis. Data are expressed as mean 6 SD.
The relation between two parameters was evaluated with a
linear regression analysis. Paired t test was used to compare
the data of the same segments before and after nitroglycerin
injection. Pooled-variance t test or Mann-Whitney U test
was used for comparisons between diabetics and nondiabet-
ics where appropriate. Discrete data were compared by
chi-square analysis. Analysis of covariance was used to
detect significant differences of a dependent variable (dis-
tensibility) between the categories of a factor (diabetes
mellitus: diabetics, nondiabetics) after controlling for a
number of variables that were used as covariates. Statistical
analyses were performed by use of the SPSS version 8.0
statistical package (SPSS Inc., Chicago, Illinois). We con-
sidered the results significant when p , 0.05.
Results. Clinical and angiographic characteristics were
similar in the two groups, except fasting blood sugar (Table
1).
Intracoronary ultrasound measurements. In the diabetics,
diastolic CSLA was 8.6 6 0.6 mm2 (range 6.98 to
10.65 mm2), atherosclerotic plaque burden was 4.45 6
0.37 mm2 (range 3.7 to 5.21 mm2) and luminal stenosis was
33 6 3%. The arc of the circumference affected by the plaque
was 120 6 20°. The maximum intima plus media thickness at
the nonplaque containing portion of the circumference was
0.9 6 0.15 mm. There were 12 fibrotic plaques, 5 soft and 3
with calcium deposits.
In the nondiabetics, diastolic CSLA was 11.5 6 0.5 mm2
(range 9.2 to 13.6 mm2), atherosclerotic plaque burden was
4.25 6 0.29 mm2 (range 3.67 to 4.81 mm2) and luminal
stenosis was 27 6 5%. The arc of the circumference affected
by the plaque was 111 6 30°. The maximum intima plus
media thickness at the nonplaque containing portion of the
circumference was 0.8 6 0.2 mm. Ten plaques were fibrotic,
nine were soft and one had calcium deposits.
Observer variability. Interobserver variability for area
measurements as depicted by standard deviation was 63.9%
whereas the correlation coefficient was r 5 0.95. Intraob-
server variability was 63.1% with a correlation coefficient of
r 5 0.96.
Coronary distensibility. In the diabetics, S-BP was 136 6
12 mm Hg (range 110 to 155 mm Hg) and D-BP was 76 6
11 mm Hg (range 52 to 93 mm Hg). Mean pulse pressure
was 60 6 12 mm Hg. After IC-NTG injection, S-BP was
121 6 20 mm Hg (range 100 to 155 mm Hg), and D-BP
Table 1. Clinical Characteristics
Nondiabetics Diabetics
p
Value
Patients 20 20 NS
Men/women 13/7 15/5 NS
Age (yr) 54 6 2 53 6 4 NS
Smokers 2 1 NS
Cholesterol
(mmol/liter)
7.13 6 1.05 7.43 6 1.55 NS
High density
lipoproteins
(mmol/liter)
0.88 6 0.18 0.86 6 0.15 NS
Triglycerides
(mmol/liter)
2.1 6 1.6 2.2 6 1.5 NS
Fasting blood glucose
(mmol/liter)
4.1 6 1.1 8.3 6 1.2 , 0.01
Glycated hemoglobin
(%)
9.1 6 0.6
Coronary artery disease
One-vessel 12 11 NS
Two-vessel 8 9 NS
Angiographic
stenosis at the
imaging site (%)
29 6 5 30 6 3 NS
Ejection fraction (%) 55 6 4 53 6 3 NS
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was 75 6 11 mm Hg (range 50 to 87 mm Hg). Mean pulse
pressure was 46 6 10 mm Hg.
Mean systolic CSLA increased from 9.5 6 0.7 mm2 to
10.6 6 0.78 mm2 after IC-NTG and mean diastolic CSLA
increased also from 8.6 6 0.6 mm2 to 9.3 6 0.8 mm2. Thus,
IC-NTG induced a 11.5% 6 6% increase in systolic CSLA
and a 8.1% 6 7% in diastolic CSLA. Consequently,
C-DIST increased from 1.73 6 0.1 mm Hg21 (range
1.56 mm Hg21 to 1.84 mm Hg21) to 3.02 6 0.14 mm
Hg21 (range 2.83 mm Hg21 to 3.31 mm Hg21) after
IC-NTG (p , 0.01), whereas beta decreased from 11.2 6
1 (range 9.8 to 13) to 7.1 6 0.4 (range 6.3 to 8) (p , 0.001).
Mean left ventricular end diastolic pressure at the end of the
study was 6.3 6 2 mm Hg.
Before IC-NTG in the nondiabetics, S-BP was 128 6
12 mm Hg (range 108 to 158 mm Hg) and D-BP was 76 6
7 mm Hg (range 55 to 95 mm Hg). Mean pulse pressure
was 52 6 12 mm Hg. After IC-NTG injection, S-BP was
111 6 12 mm Hg (range 90 to 125 mm Hg) and D-BP was
71 6 10 mm Hg (range 50 to 85 mm Hg). Mean
intracoronary pulse pressure was 40 6 10 mm Hg.
Mean systolic CSLA increased from 12.5 6 0.9 mm2 to
13.7 6 0.8 mm2 after IC-NTG. Mean diastolic CSLA
increased from 11.5 6 0.5 mm2 before IC-NTG to 11.7 6
0.9 mm2 after IC-NTG. Thus, IC-NTG induced a 9.6% 6
10% increase in systolic CSLA and 2% 6 1% in diastolic
CSLA. Therefore, C-DIST increased from 1.68 6
0.12 mm Hg21 (range 1.42 mm Hg21 to 1.95 mm Hg21)
to 4.21 6 0.15 mm Hg21 (range 4.0 mm Hg21 to 4.5 mm
Hg21) after nitroglycerin injection (p , 0.01) whereas beta
decreased from 11.7 6 3 (range 8.3 to 15.7) to 3.8 6 0.5
(range 3.0 to 4.9) (p , 0.001). Mean left ventricular end
D-BP at the end of the study was 5.8 6 2.1 mm Hg.
Thus, before IC-NTG there was no difference in S-BP
(p 5 0.06) and D-BP (p 5 0.8) between diabetics and
nondiabetics. After IC-NTG, S-BP decreased significantly
in diabetics (p , 0.01) and in nondiabetics (p , 0.01), but
absolute values of S-BP remained similar among the two
groups (p 5 0.07). However, D-BP decreased significantly
after IC-NTG only in the nondiabetics (p 5 0.04). Percent
changes in systolic CSLA induced by IC-NTG were similar
between the two groups, whereas percent changes in dia-
stolic CSLA were smaller in the nondiabetics. Although
C-DIST (p 5 0.1) and beta (p 5 0.8) were similar between
diabetics and nondiabetics at baseline, C-DIST increased
and beta decreased significantly in both groups after IC-
NTG. Furthermore, C-DIST was greater (p , 0.01) and
beta was smaller (p 5 0.001) in the nondiabetics compared
with the diabetics after IC-NTG. There was a good inverse
correlation between atheroslerotic plaque burden and
changes in C-DIST after IC-NTG in the nondiabetic
patients (r2 5 0.746, p 5 0.0001, Fig. 3) but not in the
diabetics, (r2 5 0.19, p 5 0.06, Fig. 4).
Although diabetics had coronary arteries with smaller
systolic and diastolic CSLA before and after IC-NTG
administration compared with nondiabetics (p , 0.01),
there was no significant difference in atherosclerotic plaque
burden, plaque characteristics and arc of the circumference
affected by the atherosclerotic plaque. However, the degree
of luminal stenosis was greater in diabetics compared with
nondiabetics (p 5 0.002).
No correlation was observed between changes in C-DIST
after IC-NTG and known duration of diabetes, high
density lipoprotein cholesterol, fasting glucose and glycated
hemoglobin levels.
Analysis of covariance revealed that C-DIST after IC-
NTG was significantly different between diabetics and
nondiabetics (p 5 0.021) after correction for a number of
variables that were used as covariates (age, S-BP, D-BP,
pulse pressure, plaque burden, CSLA).
In the whole patient population, C-DIST was inversely
correlated with plaque burden (p 5 0.033, r2 5 0.113).
Figure 3. Cross-sectional plaque area is plotted against the change
that occurred in C-DIST after IC-NTG in nondiabetics. A good
inverse correlation is observed (r2 5 0.746, p 5 0.0001).
C-DIST 5 coronary artery distensibility; IC-NTG 5 intracoro-
nary nitroglycerin.
Figure 4. Cross-sectional plaque area is plotted against the change
that occurred in C-DIST after IC-NTG in diabetics. There is no
good correlation between these two variables (r2 5 0.19, p 5 0.06).
Abbreviations as in Figure 3.
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DISCUSSION
Coronary artery distensibility and diabetes. Our findings
provide evidence for impaired augmentation of C-DIST
after IC-NTG, an endothelium independent vasodilator, in
patients with NIDDM. Previous studies in diabetics using
forearm blood flow measurements reported reduced respon-
siveness of the arterial smooth muscle to intrabrachial
nitroglycerin infusion (7). Our study documented similar
changes in the coronary arterial bed. This is not unexpected
because coronary arteries are affected and damaged by
diabetes more frequently than the forearm arteries. Both
impairment of the nitric oxide pathway, through which
nitroglycerin acts, and dysfunction of the arterial smooth
muscle cells would produce the same result (18). Studies in
diabetics implicate increased inactivation of nitric oxide by
oxygen-derived free radicals or advanced glycosylation end
products and abnormal response of vascular smooth muscle
to nitric oxide, involving either the receptor for guanylate
cyclase or subsequent signal transduction, as the main
mechanisms (19).
Subtle differences in the elastic properties of the coronary
arterial wall between the two groups might have not been
detected by our technique before IC-NTG in the presence
of an impaired biologic effect of nitric oxide due to athero-
sclerosis (20,21). These subtle differences may have been
revealed only after IC-NTG, an exogenous donor of ample
amounts of nitric oxide. Indeed, structural changes in
diabetics (22) may alter intrinsic vessel wall properties and
increase coronary artery stiffness. The relative short duration
of diabetes and its mild clinical course may have produced
only mild alterations in C-DIST, which were detected only
after IC-NTG. Combination of the ICUS study with tissue
characterization of the arterial wall will be necessary to
clarify the role of intrinsic factors in determining vessel
distensibility. Age and calcification of the vessel wall may
also affect distensibility (23).
In the nondiabetics, smaller percent changes in diastolic
CSLA induced by IC-NTG may be due to the significant
decrease in D-BP. Absolute levels of blood pressure will also
affect vessel distensibility (24). However, changes in beta
were in accordance with those of C-DIST.
Severe atherosclerosis in coronary artery segments is
characterized by medial smooth muscle atrophy (25). Such
structural changes may severely impair C-DIST and mask
differences between diabetics and nondiabetics. Because our
purpose was to study the effect of NIDDM on C-DIST, we
selected segments without significant CAD. Furthermore,
total atherosclerotic plaque burden was not significantly
different between the two groups of patients. We used total
atherosclerotic plaque burden as an index of the arterial wall
encroachment by the atherosclerotic process. Thus, we
assumed that we compared distensibility in coronary seg-
ments that should have responded similarly to IC-NTG
injection if NIDDM had not been present.
A good correlation between atherosclerotic plaque burden
and changes in C-DIST was observed only in nondiabetics.
This correlation was poor in diabetics, which implies that
other factors are more important determinants of C-DIST
in diabetics. However, we found a poor correlation between
increases in C-DIST after IC-NTG and known duration of
diabetes, high density lipoprotein cholesterol, fasting glu-
cose and glycated hemoglobin levels, which supports the
hypothesis that the mechanical property of the coronary
arterial wall that is represented by C-DIST is independent
of these factors. Systolic and diastolic CSLA was smaller in
diabetics at baseline, and although total plaque burden and
circumference of the artery involved appeared similar in
both groups, there may be more diffuse atherosclerosis in
the diabetics. Similarly, the larger CSLA in nondiabetics
may have influenced our results. However, analysis of
covariance revealed that C-DIST after IC-NTG differed
significantly between diabetics and nondiabetics even after
correcting for CSLA.
Our study supports the view that the presence of diabetes
mellitus is associated with reduced arterial elasticity (24) and
provides evidence that this also applies to the coronary
arteries (12). It is possible that the impaired elastic proper-
ties of the coronary arterial wall may play an important role
in the development of elastic recoil and restenosis after
coronary angioplasty in diabetics.
Study limitations. Images of ICUS represent a thin tomo-
graphic cross-section of the artery and cannot be used to
evaluate changes simultaneously in adjacent segments. The
size of the ultrasound catheter (1.17 mm) excluded seg-
ments with severe stenosis from evaluation. Measurements
of CSLA performed at diastole and systole may not refer to
the same coronary site precisely, because the position of the
transducer with respect to vessel-wall landmarks may
change during the cardiac cycle.
Although it has been shown that the distribution of the
atherosclerotic plaque affects regional augmentation of
CSLA after IC-NTG administration (13), we determined
only total vessel distensibility. This was because the intima-
media thickness at the nonplaque containing arc was beyond
the reported upper normal limits and could not be assumed
to be free of atherosclerotic changes.
We compared segments with similar total plaque burden.
However, despite the similar total atherosclerotic plaque
burden, an identical effect on the elastic behavior of the
coronary arterial wall can only be assumed.
The interval that the medications were on hold before the
study may not be enough to guarantee complete absence of
pharmacologic effects. It is also possible that other drugs,
such as lipid lowering agents, may have influenced vasore-
activity to nitroglycerin, although we consider this possibil-
ity remote.
Conclusions. Our findings help to elucidate the mecha-
nisms by which nitroglycerin acts on the coronary arteries of
diabetic patients. The results of this study indicate that
coronary arteries of diabetics may not respond as well as the
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coronary arteries of nondiabetics to nitroglycerin, a thera-
peutic agent used routinely to treat ischemic heart disease.
Reprint requests and correspondence: Dr. Manolis Vavu-
ranakis, Haimanda 24-26, Marousi 15122, Athens, Greece.
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